FGF16 and breast carcinoma: Q-PCR assay (n = 5 paired and 8 orphan; Figure 3A; P<0.005) and immuno-flourescence-based IHC analysis (n=6 Paired; Figure 3B) demonstrated elevated expression of FGF16 in human breast cancer compared to normal breast tissues.